Jack Brennan

634 total citations
8 papers, 586 citations indexed

About

Jack Brennan is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Jack Brennan has authored 8 papers receiving a total of 586 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Molecular Biology and 1 paper in Oncology. Recurrent topics in Jack Brennan's work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (2 papers). Jack Brennan is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (2 papers). Jack Brennan collaborates with scholars based in Canada, United States and United Kingdom. Jack Brennan's co-authors include Fumio Takei, Dixie L. Mager, Wilfred A. Jefferies, Jamie Freeman, Suzanne Lemieux, Gwendolyn M. Mahon, Simon Y. C. Wong, Laurie L. Parker and David D. Thomas and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Immunological Reviews.

In The Last Decade

Jack Brennan

8 papers receiving 576 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack Brennan Canada 5 561 114 44 33 32 8 586
Jonas Sundbäck Sweden 13 633 1.1× 114 1.0× 66 1.5× 31 0.9× 40 1.3× 17 672
M Y Olsson-Alheim Sweden 9 424 0.8× 87 0.8× 21 0.5× 36 1.1× 20 0.6× 11 438
Faye Chan United States 4 394 0.7× 78 0.7× 36 0.8× 30 0.9× 69 2.2× 6 443
Matthew Crooks United States 9 467 0.8× 92 0.8× 83 1.9× 11 0.3× 72 2.3× 9 585
Tonya J. Roberts United States 7 381 0.7× 46 0.4× 40 0.9× 25 0.8× 84 2.6× 9 418
Nathaniel Barton United States 4 302 0.5× 51 0.4× 36 0.8× 14 0.4× 45 1.4× 9 332
Garth Cameron Australia 8 363 0.6× 104 0.9× 35 0.8× 9 0.3× 34 1.1× 9 379
L Percival United States 7 396 0.7× 30 0.3× 80 1.8× 32 1.0× 32 1.0× 8 444
P. Julian Dyson United Kingdom 11 375 0.7× 72 0.6× 44 1.0× 19 0.6× 18 0.6× 16 407
Alina Suzann Fichtner Germany 10 327 0.6× 87 0.8× 59 1.3× 7 0.2× 26 0.8× 16 372

Countries citing papers authored by Jack Brennan

Since Specialization
Citations

This map shows the geographic impact of Jack Brennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack Brennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack Brennan more than expected).

Fields of papers citing papers by Jack Brennan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack Brennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack Brennan. The network helps show where Jack Brennan may publish in the future.

Co-authorship network of co-authors of Jack Brennan

This figure shows the co-authorship network connecting the top 25 collaborators of Jack Brennan. A scholar is included among the top collaborators of Jack Brennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack Brennan. Jack Brennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Brennan, Jack, et al.. (2021). Integrated Phosphoproteomics for Identifying Substrates of Human Protein Kinase A (PRKACA) and Its Oncogenic Mutant DNAJB1–PRKACA. Journal of Proteome Research. 20(10). 4815–4830. 4 indexed citations
2.
Brennan, Jack, et al.. (2010). Adjusting the life of a US patent due to Patent Office delay. Industrial Biotechnology. 6(1). 18–21. 1 indexed citations
3.
Brennan, Jack. (2002). Straight Talk on Investing. 1 indexed citations
4.
Takei, Fumio, Jack Brennan, & Dixie L. Mager. (1997). The Ly‐49 family: genes, proteins and recognition of class I MHC. Immunological Reviews. 155(1). 67–77. 163 indexed citations
5.
Brennan, Jack, Gwendolyn M. Mahon, Dixie L. Mager, Wilfred A. Jefferies, & Fumio Takei. (1996). Recognition of class I major histocompatibility complex molecules by Ly-49: specificities and domain interactions.. The Journal of Experimental Medicine. 183(4). 1553–1559. 93 indexed citations
6.
Brennan, Jack, Suzanne Lemieux, Jamie Freeman, Dixie L. Mager, & Fumio Takei. (1996). Heterogeneity Among Ly-49C Natural Killer (NK) Cells: Characterization of Highly Related Receptors with Differing Functions and Expression Patterns. The Journal of Experimental Medicine. 184(6). 2085–2090. 108 indexed citations
7.
Brennan, Jack, Fumio Takei, Simon Y. C. Wong, & Dixie L. Mager. (1995). Carbohydrate Recognition by a Natural Killer Cell Receptor, Ly-49C. Journal of Biological Chemistry. 270(17). 9691–9694. 62 indexed citations
8.
Brennan, Jack, Dixie L. Mager, Wilfred A. Jefferies, & Fumio Takei. (1994). Expression of different members of the Ly-49 gene family defines distinct natural killer cell subsets and cell adhesion properties.. The Journal of Experimental Medicine. 180(6). 2287–2295. 154 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026